Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
Related Experiment Video
Updated: Feb 13, 2026

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
Françoise Debart1, Christelle Dupouy1, Jean-Jacques Vasseur1
1IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.
Abstract:
Oligonucleotides (ONs) have been envisaged for therapeutic applications for more than thirty years. However, their broad use requires overcoming several hurdles such as instability in biological fluids, low cell penetration, limited tissue distribution, and off-target effects. With this aim, many chemical modifications have been introduced into ONs definitively as a means of modifying and better improving their properties as gene silencing agents and some of them have been successful. Moreover, in the search for an alternative way to make efficient ON-based drugs, the general concept of prodrugs was applied to the oligonucleotide field. A prodrug is defined as a compound that undergoes transformations in vivo to yield the parent active drug under different stimuli. The interest in stimuli-responsive ONs for gene silencing functions has been notable in recent years. The ON prodrug strategies usually help to overcome limitations of natural ONs due to their low metabolic stability and poor delivery. Nevertheless, compared to permanent ON modifications, transient modifications in prodrugs offer the opportunity to regulate ON activity as a function of stimuli acting as switches. Generally, the ON prodrug is not active until it is triggered to release an unmodified ON. However, as it will be described in some examples, the opposite effect can be sought. This review examines ON modifications in response to various stimuli. These stimuli may be internal or external to the cell, chemical (glutathione), biochemical (enzymes), or physical (heat, light). For each stimulus, the discussion has been separated into sections corresponding to the site of the modification in the nucleotide: the internucleosidic phosphate, the nucleobase, the sugar or the extremities of ONs. Moreover, the review provides a current and detailed account of stimuli-responsive ONs with the main goal of gene silencing. However, for some stimuli-responsive ONs reported in this review, no application for controlling gene expression has been shown, but a certain potential in this field could be demonstrated. Additionally, other applications in different domains have been mentioned to extend the interest in such molecules.
Insights
Stimuli-responsive oligonucleotides (ONs) offer a promising strategy to overcome delivery and stability challenges for gene silencing therapies. These prodrugs utilize transient modifications that are activated by internal or external triggers, enhancing therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- Oligonucleotides (ONs) show therapeutic promise but face hurdles like instability, poor cell penetration, and off-target effects.
- Chemical modifications have improved ON properties for gene silencing, yet challenges remain.
- Prodrug strategies, applying transient modifications, offer an alternative to enhance ON-based drug efficacy.
Purpose of the Study:
- To review stimuli-responsive oligonucleotide modifications for gene silencing applications.
- To explore how transient ON modifications can overcome limitations of natural ONs and permanent modifications.
- To categorize stimuli-responsive ONs based on the type of stimulus and modification site.
Main Methods:
- Review of scientific literature on stimuli-responsive oligonucleotides.
- Categorization of modifications based on stimuli (chemical, biochemical, physical) and nucleotide sites (phosphate, nucleobase, sugar, extremities).
- Analysis of ON prodrug strategies for gene silencing and potential applications.
Main Results:
- Stimuli-responsive ONs can be triggered by various internal/external stimuli like glutathione, enzymes, heat, or light.
- Modifications can occur at different nucleotide positions, influencing ON activity.
- While gene silencing is the primary goal, some molecules show potential in other domains.
Conclusions:
- Stimuli-responsive ONs represent a significant advancement in developing effective gene silencing agents.
- Transient modifications offer tunable ON activity, addressing stability and delivery issues.
- Further research into stimuli-responsive ONs could unlock broader therapeutic and biotechnological applications.
Related Concept Videos
Prodrugs
Prodrugs help overcome...
Organization of Genes
Gene Flow
Responses to Salt Stress
Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

